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Over the last few years, SC have gained popularity and especially so in adolescents and young adults. A recent US survey of SC use among students shows a prevalence of 7.4-7.9 % in those aged 15/18 years, with Spice products being the second most used drugs after Marijuana (Johnston et al., 2013) .
SC identified in herbal mixtures can be classified into at least 7 categories: cyclohexylphenol (cannabicyclohexanol, CCH and CP-47497), classical cannabinoids (HU-210), naphthoylindoles (JWH-018 and JWH-073), phenylacetylindoles , benzoylindoles (AM-694 and RCS-4), naphthoylnaphthalenes (CB-13), adamantylindoles (APICA) and adamantylindazoles (AKB-48 ''APINACA''and its 5-F derivative). SC intake has been associated with the occurrence of florid/acute transient psychosis, relapse/worsening of a preexisting psychosis, persisting psychotic disorders/"spiceophrenia", and manic-like symptoms or relapse of pre-existing bipolar disorder (Papanti et al., 2013; Spaderna et al, 2013; van Amsterdam et al, 2015) . A number of analytically confirmed accidental deaths/suicides have been related to SC ingestion, either on their own or in combination with other compounds  M A N U S C R I P T
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5 the above compounds act as full agonists, in contrast to the partial agonist activity of THC (Huffman et al., 2005; Atwood et al., 2010 Atwood et al., , 2011 Marshell et al., 2014) .
.JWH-018 has been recently shown to be self-administered i.v. by rats and mice, to increase extracellular dopamine (DA) in the shell of the nucleus accumbens (NAc) and to reduce GABA-A receptor inhibition of ventral tegmental area DA neurons in a cannabinoid receptor-dependent fashion (De Luca et al., 2015) . These properties indicate that JWH-018 demonstrates positive reinforcing properties and resembles THC in its DA stimulant properties on DA transmission in the NAc (Tanda et al., 1997; Lecca et al., 2006; De Luca et al., 2012) . benzimidazole core replacing the indole (e.g. AKB-48, 5F-AKB-48, FUBIMINA), replacement of the carbonyl link of JWH-018 with carboxamide or carboxylate groups (e.g. APICA, SDB005), quinolinyl (PB-22 ''QUPIC'', 5F-PB-22, BB-22 ''QUCHIC'') or non-cyclic (ABDICA, AB-PINACA, 5F-AB-PINACA) secondary structures and novel nitrogenized tails (AB-FUBINACA, AB-FUBICA) (Uchiyama et al., 2012; 2013 a,b; ACMD, 2014) .
To date, detailed information on the affinity, agonist potency, intrinsic activity and in vivo effects of these 3 rd generation cannabinoids is lacking. As part of our continuing interest on the mechanism of the reinforcing properties and abuse liability of natural and synthetic cannabinoids, we selected four of the 3 rd generation cannabinoids found in Spice/K2 products, namely BB-22, 5F-PB-22, 5F-AKB-48 (also known as 5F-APINACA) and STS-135. In the UK, synthetic
cannabinoids are the most frequently represented Novel Psychoactive Substance (NPS) category identified in samples submitted for analysis by a range of sources, with 5F-AKB-48 and 5-FPB-22
('clockwork orange'; 'exodus'; and others) having been reported as the most identified NPS molecules overall (Wedinos, 2014) . The recent trend of SC fluorination may increase the compounds' lipophilicity, hence enhancing the absorption through biological membranes/blood brain barrier (Schifano et al., 2015) . The fluorinated SC STS-135 can be identified either on its own ('clockwork orange' and others) or in combination with other 'spice' molecules in products such as 'Moroccan' (Wedinos, 2014) . Similarly, 5F-PB-22 ('Psyclone' and others) is the terminally fluorinated analogue of QUPIC (also known as PB-22). Psyclone incense is priced around £10 per gram, with users reporting intense and long-lasting euphoria/relaxation/visual hallucinations effects (Santacroce et al., 2015) . Furthermore, BB-22, identified in products such as 'Vertex' and others, has recently been associated with a range of hospitalizations in the UK (Plymouth Herald, 2015) . In this study, the above compounds' binding and agonist properties on native CB1 receptors in brain homogenates from rats and mice have been investigated. In addition, the in vivo effects on DA transmission, as monitored by brain microdialysis, of the compound which provided with the highest potency and efficacy as an agonist of CB1 receptors, namely BB-22, was studied in detail.
Thus, the effect of BB-22 on DA transmission in the rat NAc shell and core and medial prefrontal cortex (mPFC) was investigated. The in vivo effects of the other three compounds on NAc shell DA transmission was also tested.
MATERIALS AND METHODS

Animals
Male Sprague-Dawley rats (Harlan Italy), C57BL/J6 and CB1 knockout (KO) mice (originally bred on C57BL/6J background were kindly donated by Dr Aron H. Lichtman, Department of Pharmacology and Toxicology, Virginia, Commonwealth, Virginia) were used for in vitro experiments (rats of 200-250g and mice of 17-20 g, respectively) and for in vivo microdialysis (rats of 275-300 g). Rats and mice were housed 4 and 10 per cage, respectively, in standard plastic cages M A N U S C R I P T A C C E P T E D Tocris (Bristol, UK). 5F-AKB-48, 5F-PB-22, BB-22, and STS-135 were purchased from an Internet source (www.researchchemist.co.uk).
For biochemical experiments, drugs were dissolved in dimethyl sulfoxide (DMSO). The DMSO concentration used in the different assays never exceeded 0.1% (v/v) and had no effects on
To confirm their identity and purity, the substances were evaluated using gas chromatography mass spectrometry with electron ionisation (GC-EI-MS), 400 MHz nuclear magnetic resonance spectroscopy (NMR), and high performance liquid chromatography (HPLC) . Reference standards of the four cannabinoids were purchased from Chiron (Norway) for comparison. GC-EI-MS was used for the initial identification where the fragmentation pattern of all four Internet products correlated to the cannabinoid claimed on the label, when compared to that of the reference standard as well as the SWG Drug library (Version 2.1). The identification was further confirmed using NMR where the number of peaks and splitting patterns were consistent with the cannabinoid chemical structures and in line with spectra produced by SWG Drug. HPLC was then used to evaluate the purity of the cannabinoid products where the purity of 5F-AKB-48, 5F-PB-22, BB-22, and STS-135 were determined to be 93 ± 1%, 95.2 ± 0.8%, 90.6 ± 0.6%, and 91 ± 2%, respectively.
Full methods and data interpretation are available in the Supplementary Information. (concentration of agonist to obtain 50% of the maximal effect) values.
In
2.5
In vivo microdialysis 2.5.1 Surgery. Male Sprague-Dawley rats (275-300 g; Harlan, Italy) were anaesthetised with Equitesin (3ml/kg ip; chloral hydrate 2.1 g, sodium pentobarbital 0.46 g, MgSO 4 1.06 g, propylene glycol 21.4 ml, ethanol (90%) 5.7 ml, H 2 O 3 ml) placed in a stereotaxic apparatus and implanted with vertical dialysis probes (1.5 or 3 mm dialyzing portion for NAc or mPFC, respectively) in the NAc shell (A+2.2, L+1.0 from bregma, V-7.8 from dura) or core (A+1.4; L+1.6 from bregma; V-7.6 from dura) or in the mPFC (A+3.7, L+0.8 from bregma, V-5.0 from dura), according to the rat brain atlas of Paxinos and Watson (1998) . In order to perform intravenous (i.v.) drug administration, a catheter (Silastic, Dow Corning Corporation, Michigan, USA) was inserted in the right jugular vein as previously described (De Luca et al., 2014) .
Analytical Procedure.
On the day following surgery, probes were perfused with Ringer's solution (147 mM NaCl, 4 mM KCl, 2.2 mM CaCl 2 ) at a constant rate of 1 µl/min. Dialysate samples (10 µl) were injected into an HPLC equipped with a reverse phase column (C8 3.5 um, Waters, USA) and a coulometric detector (ESA, Coulochem II) to quantify DA. The first electrode of the detector was set at +130 mV (oxidation) and the second at -175 mV (reduction). The composition of the mobile phase was: 50 mM NaH 2 PO 4 , 0.1 mM Na 2 -EDTA, 0.5 mM n-octyl sodium sulfate, 15% (v/v) methanol, pH 5.5. The sensitivity of the assay for DA was 5 fmol/sample.
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11 2.5.3 Histology. At the end of the experiment, animals were sacrificed and their brains removed and stored in formalin (8%) for histological examination to verify the correct placement of the microdialysis probe.
Statistical Analysis
All the numerical data are given as mean ± SEM. Data were analyzed by utilizing one-way ANOVA or repeated measures ANOVA or T-test. Results from treatments showing significant overall changes were subjected to Tukey's tests or Dunnett's tests for post hoc comparisons, with significance for p < 0.05.
RESULTS
IN VITRO STUDIES
Agonist-stimulated [
S]GTPγS binding
As shown in Fig. 2 A- respectively, of the basal activity. BB-22, 5F-PB-22, 5F-AKB-48, and STS-135 produced greater G-protein stimulation than the full CB1 receptor agonist, WIN. Specifically, the stimulation of GTPγS induced by 1 µM of BB-22 and 5F-PB-22 was significantly (p<0.01) greater than the amount of stimulation produced by WIN (Fig. 1A) . WIN and all compounds produced no GTPγS stimulation when co-incubated with AM 251 (0.1 µM), a CB1 receptor antagonist/inverse agonist ( Fig. 2 A-B) , suggesting that all four test compounds activate a G protein coupled to the CB1 receptor.
[ 35 S]GTPγS binding was stimulated in a concentration-dependent and saturable manner by the prototypic indole-derived synthetic cannabinoid JWH-018 and by all four synthetic cannabinoids 5F-AKB-48, STS-135, BB-22 and 5F-PB-22 (Fig. 3 , Table 1 ). All compounds possess nanomolar potency at CB1 receptors, with BB-22 and 5F-PB-22 being approximately 5-7 fold more potent than JWH-018. EC 50 values for BB-22 and 5F-PB-22 were significantly lower than EC 50 value for JWH-018 (ANOVA: F (4,14) = 14.78, P< 0.0001, p<0.05, Dunnett's test), while no difference was M A N U S C R I P T
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12 recorded in the EC 50 value for STS-135 and 5F-AKB-48 (ANOVA: F (4,14) = 14.78 P< 0.001).
These latter compounds display similar potency to JWH-018 for stimulating GTPγS binding-CB1 mediated (Table 1) . The maximal efficacy (Emax) of G-protein activation by JWH-018 and STS-135 was similar while the other compounds (5F-AKB-48, BB-22 and 5F-PB-22) exhibited significant enhanced efficacy compared to JWH-018 (ANOVA F (4,14) = 11.56 P< 0.001). The rank order of potency and efficacy was BB-22 = 5FP-22 > JWH-018 = 5F-AKB-48= STS-135 and BB-22 = 5FP-22 > 5F-AKB-48> STS-135 = JWH-018, respectively (Table 1) . Lastly, to confirm the involvement of the cannabinoid CB1 receptor in the activation of G protein we performed concentration-effect curves of our compounds in mouse cortex membrane homogenates of CB1-KO and wild-type mice. As shown in Fig. 4 5.7 nM and 158 ± 2.4 %, 28 ± 3.2 nM and 167 ± 3.7 %, 15 ± 1.7 nM and 159 ± 1.5 %, 4 ± 0.9 nM and 183 ± 5.5 %, 1.46 ± 0.14 nM and 187 ± 3.6 %, for JWH-018, 5F-AKB-48, STS-135, 5F-PB-22
and BB-22, respectively. Importantly, no activation of G protein was observed in CB1-KO mice.
Effects of JWH-018, 5F-AKB48, STS-135, BB-22 and 5F-PB-22 on cannabinoid CB1 receptor binding
To determine the affinity of JWH-018 and the other compounds to the CB1 receptor, we used a radiolabelled competition binding assay in rat cortical membranes. Indeed, high levels of CB1 receptors are expressed in the central nervous system, while only negligible CB2 receptors quantities are present (Pertwee, 2005) . In good agreement with previous published data ( Devane et al., 1988; Thomas et al., 1998) M A N U S C R I P T
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13 lower compared to our reference compound JWH-018, with the rank order of CB1 receptor affinity BB-22 = 5FPB-22 > 5F-AKB-48 > STS-135 > JWH-018 (Table 1) .
IN VIVO MICRODIALYSIS STUDIES
Rat basal values of DA, expressed as fmoles/10 µl sample (mean ± SEM), were: NAc shell 52 ± 5
(N =50), NAc core 55 ± 4 (N =25), mPFC 16± 2 (N =21). 
Effect of BB-
Role of CB1 receptors on the NAc shell DA stimulation induced by BB-22
In this experiment, we studied the effect of CB1 receptor blockade by the inverse agonists/antagonists AM 251 on the NAc shell DA response to BB-22 (0.01 mg/kg i.v.) in rats (Fig.   7 ). In AM 251 pre-treated animals, two-way ANOVA showed a main effect of treatment 
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14 hoc tests revealed that pre-treatment with AM-251 significantly reduced dialysate DA in the NAc shell as compared to rats pre-treated with vehicle (90, 140,150,180 min sample).
Effect of 5F-PB-22, 5F-AKB-48, and STS-135 administration on DA transmission in the NAc shell
In this set of experiments, we studied the effect of 5F-PB-22, 5F-AKB-48, and STS-135 on extracellular DA levels in the NAc shell. As shown in Fig. 8 the NAc shell after all the cannabinoids tested revealing differences at the 30 and 40 min samples with respect to basal value (5F-PB-22); at the 60, 100 and 150 min samples with respect to basal value and at the 60 and 100 min samples compared to vehicle (5F-AKB-48); at the 60 min sample with respect to basal value and to vehicle (STS-135).
DISCUSSION
The main findings of this study are that the four 3 rd generation cannabinoids, BB-22, 5F-PB-22, 5F-AKB-48 and STS-135 are high affinity ligands and potent full agonists at the native rat and mice brain CB1 receptors and stimulate in vivo DA transmission in the NAc shell at doses consistent with their in vitro CB1 receptor affinity. Our in vitro findings demonstrate that BB-22, 5F-PB-22, 5F-AKB-48 and STS-135 bind with nanomolar affinity to CB1 receptors in rat cerebral cortex homogenates and stimulate CB1-induced [ Previous research has shown that JWH-018, our reference compound, binds with and activates CB1 receptors with high affinity and potency and displays in vivo cannabimimetic activity, i.e., antinociception, hypothermia, catalepsy and locomotor suppression (Brents et al., 2011; Wiley et Interestingly, the stimulation of dialysate DA in the NAc shell took place within a rather narrow range of doses, a feature that differentiates these compounds from THC as well as from psychostimulants, nicotine and narcotic drugs of abuse (Di Chiara et al, 2004; Pontieri et al., 1995 and 1996; Tanda et al., 1997) . The other three compounds were tested for their effects on dialysate DA in the NAc shell at a single dose level, selected on the basis of the ratio between the Ki of JWH-018 and BB-22 for CB1 receptors and the doses of the same compounds that activate in vivo M A N U S C R I P T
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NAc shell DA transmission. Thus, doses of 0.01 mg/kg i.v. of 5F-PB-22, 0.1 mg/kg of 5F-AKB-48 and 0.15 mg/kg of STS-135 were tested. At these doses, all compounds increased dialysate DA in the NAc shell to a similar extent to BB-22 (max < 50% over basal). In the case of 5F-AKB-48 the increase of dialysate DA was delayed. In the case of BB-22 the biphasic time-course of dialysate DA in the NAc shell could be due to the formation of active metabolites while the delayed effect of 5F-AKB-48 might be due to slow passage through the blood-brain-barrier due to steric hindrance related to the bulky adamantyl residue.
In conclusion Users do not seem to be aware of the serious adverse effects related to SC misuse, since these compounds may be perceived to be somehow equivalent to Marijuana and hence "safe" and "natural" (Santacroce et al., 2015; Schifano et al., 2015) .
Appropriate, non-judgemental, prevention campaigns with a special focus on the differences between SC and cannabis may need to be organized on a large scale. At the same time, clinicians need to be regularly updated about NPS, including SC, to promptly recognize signs/symptoms of intoxication (Simonato et al., 2013; Papanti et al., 2014; Schifano et al., 2015) . Data represent a typical experiment out of three independent experiments. EC 50, of Wild-Type mice:
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BB-22 (black squares), 1.7 nM; 5F-PB-22 (red triangles), 3.4 nM; 5F-AKB-48 (green triangles), M A N U S C R I P T Data are expressed as means ± SEM of at least four independent experiments, each performed in triplicate. The calculation of IC 50 was performed by non-linear curve fitting of the concentrationeffect curves using GraphPad Prism. The F-test was used to determine the best approximation of a non-linear curve fit to one or two site models (p < 0.005). IC 50 values were converted to Ki values by means of the Cheng and Prusoff equation (Cheng and Pursoff, 1973) . 
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HIGHLIGHTS
• STS-135, 5F-AKB-48, BB-22, 5F-PB-22 are 3 rd generation Spice/K2 synthetic cannabinoids
• They are CB1 receptor ligands with higher affinity than JWH-018
• They are CB1 agonists with higher potency and intrinsic activity than JWH-018
• They increase NAc shell dopamine at doses consistent with their in vitro potency
